Correlation Between Pfizer and Materialise

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Materialise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Materialise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Materialise NV, you can compare the effects of market volatilities on Pfizer and Materialise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Materialise. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Materialise.

Diversification Opportunities for Pfizer and Materialise

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Materialise is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Materialise NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Materialise NV and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Materialise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Materialise NV has no effect on the direction of Pfizer i.e., Pfizer and Materialise go up and down completely randomly.

Pair Corralation between Pfizer and Materialise

Assuming the 90 days trading horizon Pfizer Inc is expected to under-perform the Materialise. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.01 times less risky than Materialise. The stock trades about -0.02 of its potential returns per unit of risk. The Materialise NV is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  545.00  in Materialise NV on October 25, 2024 and sell it today you would earn a total of  205.00  from holding Materialise NV or generate 37.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Materialise NV

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Materialise NV 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Materialise NV are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Materialise unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Materialise Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Materialise

The main advantage of trading using opposite Pfizer and Materialise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Materialise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Materialise will offset losses from the drop in Materialise's long position.
The idea behind Pfizer Inc and Materialise NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account